Abstract

Ciliated hepatic foregut cyst (CHFC) is a rare cystic liver disease that predominantly affects adult men and is usually asymptomatic. From embryonic of the foregut origin, CHFC presents the average size of 3.6 cm and they are well defined, are unilocular and are located in the medial segment of the left hepatic lobe. Diagnosis is based on incidental finding in radiological examinations which are with hypoechoic images on ultrasound, hypo or isoattenuating on computer tomography and hyperintense on T2 ponderation on MRI. Definitive diagnosis is given with the histological study evidencing the four layers typical of the cyst wall. The monitoring is important because of the possibility of malignant transformation in about 5% of cases. This theme has relevance due to the increase in incidence, difficulty of diagnosis, complications and the lack of knowledge of the scientific community. The purpose of this literature review is to demonstrate the importance of the diagnosis, the clinical-diagnostic features and suspicion of the frame. A review was made on the period from March 2014 to July 2015. The descriptors used were: "ciliated hepatic foregut cyst"; "diagnosis of ciliated hepatic foregut cyst" and "image of ciliated hepatic foregut cyst". We emphasize the importance of CHCH as a differential diagnosis for cystic lesions of the liver, given its importance for symptomatic patients with lesions and to patients that are asymptomatic, due of the risk of malignancy described in the literature. The complementary propaedeutic is indispensable to elucidate the diagnosis, being essential the histopathological study.

Highlights

  • Ciliated hepatic foregut cyst (CHFC) is a rare cystic liver disease that predominantly affects adult men and is usually asymptomatic

  • CHFC presents the average size of 3.6 cm

  • Diagnosis is based on incidental finding in radiological examinations

Read more

Summary

Material e métodos

Foi realizada uma revisão bibliográfica nas bases de dados eletrônicas SCIELO, MEDLINE, PUBMED, GOOGLE ACADÊMICO, no período de março de 2014 a julho de 2015. É sabido o risco de malignização, em torno de 5% dos casos, sendo recomendado a excisão cirúrgica para cisto maiores que 4-5 cm, sintomáticos,quando há um aumento progressivo do tamanho do cisto, lesões assintomáticos com alterações da parede do cisto, componente sólido no cisto e alteração da função hepática não elucidada. A injeção esclerosante de álcool absoluto percutâneo, a escleroterapia, não é recomendada, pois pode modificar características radiológicas ou dificultar o diagnóstico de futura transformação maligna.[34,35] O caráter genético da doença não foi sugerido na literatura, no entanto, há o relato de um paciente de 56 anos, coreano, diagnosticado com CCH com histórico familiar de uma filha, diagnosticada ainda na infância com cisto broncogênico. Porém alguns autores defendem a excisão cirúrgica do CCH apenas para cistos maiores que 4-5 cm, sintomáticos, quando há um aumento progressivo do tamanho do cisto, lesões assintomáticos com alterações da parede do cisto, componente sólido no cisto e alteração da função hepática sem causa encontrada.[14,15,33]

Considerações finais
Findings
Conflito de interesse
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call